BeiGene's Guangzhou Biopharmaceutical Base officially commercializes the production of Baizean® and starts dual-base production

On April 8, innovative pharmaceutical company BeiGene (Nasdaq: BGNE) (06160.

On-site celebration ceremony

On-site celebration ceremony

Previously, BeiGene’s tislelizumab injection was commissioned by Boehringer Ingelheim (China) to produce.

After the Guangzhou production base officially starts commercial production, the production line of BeiGene and Boehringer Ingelheim (China) will continue to operate, forming a Bazeran® dual-base production model.

PD-1 ushered in a new era of medical insurance, huge room for market expansion

On March 1, 2021, the latest version of the National Medical Insurance Drug List was officially launched.

In response, Dr.

" Despite fierce competition, the current domestic PD-1 market is still a blue ocean market.

Guangzhou production base global quality, global supply

Guangzhou production base global quality, global supply

It is reported that, in order to achieve the perfection of BeiGene's entire value chain from R&D, production to commercialization, the Guangzhou base of BeiGene has established a set of internationally leading quality management systems, adhering to the construction goal of "global quality, global supply".

It is understood that BeiGene has invested a total of 2.

At present, the plant has built a production capacity of 54,000 liters.

It is worth noting that BeiGene aims to build the Guangzhou production base into an industry-leading China Industry 4.

Through artificial intelligence, the Guangzhou production base will be built into an industry-leading demonstration base of China's Industry 4.

In addition, its upcoming third plant has optimized and upgraded the technology of key links such as raw solution production and preparation production, and has begun to adopt multiple large-scale stainless steel reactors, so that the original one-time production line can reduce costs while increasing efficiency.

According to Michael Garvey (Gao Wei), senior vice president of BeiGene and head of global technical operations: "The localization of key materials is an important goal of BeiGene's Guangzhou production base.

"The localization of key materials is an important goal of BeiGene's Guangzhou production base.
In the future, the Guangzhou production base will change from 37% of the original local imported materials to 73%, and realize the domestic sales of shutdown technology, and continue to optimize and upgrade.
.
"